NCT Number: NCT00358475
Study Of Perennial Allergic Rhinitis
This study was designed to assess safety of an investigational nasal spray in the treatment of perennial allergic rhinitis. Perennial allergic rhinitis is triggered by house dust, mite and mold etc. Typical symptoms are sneezing, nasal congestion and pruritus and rhinorrhea.
Looking for future studies?
Notify MeKey information
Conditions
Age range
16 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Informed consent.
- Outpatient.
- Diagnosis of perennial allergic rhinitis with symptoms.
- Able to comply with study procedures.
Exclusion criteria
- Significant concomitant medical condition.
- Use of corticosteroids/allergy medications.
- Laboratory abnormality.
- Positive pregnancy test.
Treatment and study plan
GW685698
DrugPrimary outcomes
-
Adverse events and laboratory blood test
Secondary outcomes
-
Change of nasal symptom score
Sponsors and collaborators
Lead sponsor
GlaxoSmithKline
Industry
Registry information
Official study title
Study of Perennial Allergic Rhinitis -Long Term Treatment Study-
Important dates
- Study start
- 2005
- Primary completion
- 2005
- Study completion
- 2005
- First posted
- Jul 31, 2006
- Registry last updated
- Aug 31, 2018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683)
NCT00406783
Hypersensitivity, Hypersensitivity, Immediate
View Trial DetailsObservation of Side Effects and Effectiveness of Desloratadine (Aerius) Syrup in Filipino Children (Study P05634)
NCT00761527
Hypersensitivity, Hypersensitivity, Immediate
View Trial DetailsShort and Mid-term Repeatability of Active Anterior Rhinomanometry (AAR) Measurements in Paediatric Age
NCT03286049
Hypersensitivity, Hypersensitivity, Immediate
Palermo, Sicily, Italy
View Trial DetailsObservation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED)
NCT00762983
Hypersensitivity, Hypersensitivity, Immediate
View Trial Details